Search research articles
Contact Us
Filters
Showing results (41-50 of 189) with videos related to
Page
of 19
Sort By:
Journal of Clinical Medicine
|
August 26, 2023
Intracardiac Thrombi in Morbus Adamantiades-Behçet in Two Swedish Patients
Raffaele Da Mutten, Alexander Borg, Katerina Chatzidionysiou, et al.
Kidney International Reports
|
October 21, 2024
Response to Comment on "Effect of Belimumab on Preventing <i>De Novo</i> Renal Lupus Flares"
Ioannis Parodis, Alvaro Gomez, Julius Lindblom, et al.
Best Practice & Research. Clinical Rheumatology
|
December 6, 2023
Reframing health disparities in SLE: A critical reassessment of racial and ethnic differences in lupus disease outcomes
Ioannis Parodis, Cristina Lanata, Dionysis Nikolopoulos, et al.
Autoimmunity Reviews
|
August 26, 2023
Is per-protocol kidney biopsy required in lupus nephritis?
Ioannis Parodis, Gabriella Moroni, Marta Calatroni, et al.
Rheumatology (Oxford, England)
|
May 25, 2023
Determinants of neuropsychiatric flares in patients with systemic lupus erythematosus: results from five phase III trials of belimumab
Leonardo Palazzo, Julius Lindblom, Nursen Cetrez, et al.
ARP Rheumatology
|
February 18, 2024
Lessons learnt from the recent recommendations for the non-pharmacological management of systemic sclerosis
Tânia Santiago, Ruben Fernandes, Ricardo Ferreira, et al.
Journal of Clinical Medicine
|
April 9, 2024
Factors Associated with Survival and Discontinuation of Anti-Malarial Agents in Systemic Lupus Erythematosus: Results from a Tertiary Swedish Referral Centre
Tomas Walhelm, Lina Wirestam, Yvonne Enman, et al.
Journal of Clinical Medicine
|
October 14, 2023
B Cell Tolerance and Targeted Therapies in SLE
Ioannis Parodis, Xuan Long, Mikael C I Karlsson, et al.
Rheumatology (Oxford, England)
|
February 25, 2024
Lupus Low Disease Activity State and organ damage in relation to quality of life in systemic lupus erythematosus: a cohort study with up to 11 years of follow-up
Ioannis Parodis, Thomas Haugli-Stephens, Annica Dominicus, et al.
Autoimmunity Reviews
|
August 14, 2019
Antimalarial agents diminish while methotrexate, azathioprine and mycophenolic acid increase BAFF levels in systemic lupus erythematosus
Borja Hernández-Breijo, Alvaro Gomez, Sofia Soukka, et al.
Page
of 19
Search research articles
Search
Showing results (41-50 of 189) with videos related to
Sort By:
Page
of 19
Journal of Clinical Medicine
|
August 26, 2023
Intracardiac Thrombi in Morbus Adamantiades-Behçet in Two Swedish Patients
Raffaele Da Mutten, Alexander Borg, Katerina Chatzidionysiou, et al.
Kidney International Reports
|
October 21, 2024
Response to Comment on "Effect of Belimumab on Preventing <i>De Novo</i> Renal Lupus Flares"
Ioannis Parodis, Alvaro Gomez, Julius Lindblom, et al.
Best Practice & Research. Clinical Rheumatology
|
December 6, 2023
Reframing health disparities in SLE: A critical reassessment of racial and ethnic differences in lupus disease outcomes
Ioannis Parodis, Cristina Lanata, Dionysis Nikolopoulos, et al.
Autoimmunity Reviews
|
August 26, 2023
Is per-protocol kidney biopsy required in lupus nephritis?
Ioannis Parodis, Gabriella Moroni, Marta Calatroni, et al.
Rheumatology (Oxford, England)
|
May 25, 2023
Determinants of neuropsychiatric flares in patients with systemic lupus erythematosus: results from five phase III trials of belimumab
Leonardo Palazzo, Julius Lindblom, Nursen Cetrez, et al.
ARP Rheumatology
|
February 18, 2024
Lessons learnt from the recent recommendations for the non-pharmacological management of systemic sclerosis
Tânia Santiago, Ruben Fernandes, Ricardo Ferreira, et al.
Journal of Clinical Medicine
|
April 9, 2024
Factors Associated with Survival and Discontinuation of Anti-Malarial Agents in Systemic Lupus Erythematosus: Results from a Tertiary Swedish Referral Centre
Tomas Walhelm, Lina Wirestam, Yvonne Enman, et al.
Journal of Clinical Medicine
|
October 14, 2023
B Cell Tolerance and Targeted Therapies in SLE
Ioannis Parodis, Xuan Long, Mikael C I Karlsson, et al.
Rheumatology (Oxford, England)
|
February 25, 2024
Lupus Low Disease Activity State and organ damage in relation to quality of life in systemic lupus erythematosus: a cohort study with up to 11 years of follow-up
Ioannis Parodis, Thomas Haugli-Stephens, Annica Dominicus, et al.
Autoimmunity Reviews
|
August 14, 2019
Antimalarial agents diminish while methotrexate, azathioprine and mycophenolic acid increase BAFF levels in systemic lupus erythematosus
Borja Hernández-Breijo, Alvaro Gomez, Sofia Soukka, et al.
Page
of 19